- ASSOCIATE PROFESSOR Genetics and Genomic Sciences
- ASSISTANT PROFESSOR Medicine
MBBS, Topiwala National Medical College
Residency, Internal Medicine
North Shore Univ. Hosp. at Forest Hills
Fellowship, Medical Genetics
Mount Sinai Hospital
Fellowship, Biochemical Genetics
Mount Sinai Hospital
- Board Certification: Internal Medicine, Clinical Genetics
ResearchCurrent Research: Modifier Genes in Type I Gaucher disease
Balwani M, Smukler L, Edelmann L, Kornreich R, Desnick RJ. Type 1 Gaucher Disease: Significant Disease manifestations in “asymptomatic homozygotes” . Arch. Inter. Med;.
Cantatore-Francis JL, Cohen J, Balwani M, Desnick RJ, Schaffer JV. Hepatoerythropoietic Porphyria misdiagnosed as child abuse: cutaneous and hematologic manifestations in siblings with a novel UROD mutation. Arch. Dermatol.;.
Balwani M, Fuerstman L, Desnick RJ, Buckley B, McGovern MM. Use of complimentary and alternative medicine by patients with lysosomal storage diseases. Genet. Med 2009; 11(722-727).
Hermann G, Simpson WL, Balwani M. A Gaucher-kor manifesztacioi a csontrendszerben (The manifesations of Gaucher disease in the skeletal system).. Osteologiai Kozlemenyek (Skeletal Radiology) 2008; 3(121-128).
Carreiro J, Balwani M, Grosskreutz C, Isola L, Malone A, Scigliano E, Osman K. A case report of secondary autograft failure due to Gaucher disease. Am. J. Hematol 2008; 83(937).
Grace ME, Balwani M, Nazarenko I, Prakash-Cheng A, Desnick RJ. Type I Gaucher Disease: null and hypomorphic novel chitotriosidase gene mutations- implications for diagnosis and therapeutic monitoring. . Hum. Mut. 2007; 28(28:866-873).
Sansaricq C, Pardo S, Balwani M, Grace M, Raymond K. Biochemical and molecular diagnosis of lipoamide dehydrogenase deficiency in a North American Ashkenazi Jewish family. . J. Inherit. Metabol. Dis. 2006; 29(203-204).
Anderson KE, Lee C, Balwani M, Desnick RJ. Porphyrias. In: Nelson Textbook of Pediatrics, Behrman, R.E., Kleigman, R.M. and Jenson, H.B., Eds., . W.B. Saunders Company, Philadelphia;(19).
Balwani M, Prakash-Cheng A, Desnick RJ. Encyclopedia of Molecular Mechanisms of Disease, F. Lange, Ed., . Springer-Verlag GmbH Heidelberg, Germany, pp 2009;(691-692).
Sansaricq C, Balwani M. Essential Pediatric Endocrinology and Inborn Errors of Metabolism. Kyriakie Sarafoglou, McGraw Hill 2008;.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Balwani during 2014 and/or 2015. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Scientific Advisory Board:
- Genzyme Corporation; Recordati Rare Diseases, Inc. (RRD)
Other Activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership.
- Genzyme Corporation
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Atran Berg Laboratory Building Floor 1st Floor, Room AB1-50
1428 Madison Avenue
New York, NY 10029
1184 Fifth Avenue, 2nd Floor
Gaucher and Porphyria Disease patients only
New York, NY 10029
- Tuesday 9:00am - 4:00pm
- Wednesday 9:00am - 4:00pm
- Thursday 9:00am - 4:00pm
- Friday 9:00am - 12:00pm